Patent assignee · FR · COMPANY

INNATE PHARMA

🏢 View company profile →
93Patents
88Active
93Granted
53Portfolio score

Filing activity: Dec 27, 2001 → Jun 30, 2022 · 16 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8119775B2 Human anti-KIR antibodies Chemistry; Metallurgy 38 Active
US9764038B2 Enzymatic conjugation of antibodies Chemistry; Metallurgy 23 Active
US9447185B2 Compositions and methods for treating proliferative disorders Human Necessities 21 Active
US9067997B2 Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders Emerging Cross-Sectional Technologies 20 Active
US9427478B2 Enzymatic conjugation of polypeptides Chemistry; Metallurgy 17 Active
US8993319B2 Monoclonal antibodies against NKG2A Physics 16 Active
US7803376B2 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds Physics 16 Active
US10329348B2 Treatment of cancers using anti-NKG2A agents Chemistry; Metallurgy 15 Active
US10059765B2 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds Physics 15 Active
US10160810B2 Monoclonal antibodies against NKG2A Physics 14 Active
US8981065B2 Human anti-KIR antibodies Chemistry; Metallurgy 13 Active
US9717803B2 Enzymatic conjugation of polypeptides Chemistry; Metallurgy 12 Active
US9090876B2 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds Physics 12 Active
US7732131B2 Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor Chemistry; Metallurgy 10 Active
US10113003B2 Multispecific NK engager proteins Chemistry; Metallurgy 9 Active
US8637258B2 Compositions and methods for regulating NK cell activity Chemistry; Metallurgy 9 Active
US9828427B2 Anti-KIR3D antibodies Chemistry; Metallurgy 8 Active
US9181341B2 Anti-KIR3D antibodies Chemistry; Metallurgy 8 Active
US8017596B2 Phosphonates useful as modulators of T-γ-9-δ-2 activity Chemistry; Metallurgy 8 Active
US6979546B2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same Emerging Cross-Sectional Technologies 8 Expired
US10174112B2 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma Physics 8 Active
US10711063B2 Neutralization of inhibitory pathways in lymphocytes Chemistry; Metallurgy 7 Active
US10280222B2 Humanized antibodies with increased stability Chemistry; Metallurgy 7 Active
US9902936B2 PAN-KIR2DL NK-receptor antibodies and their use in diagnostics and therapy Emerging Cross-Sectional Technologies 7 Active
US10434180B2 Enzymatic conjugation of polypeptides Chemistry; Metallurgy 7 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.